BioCentury
ARTICLE | Clinical News

Asord becocalcidiol: Phase II started

January 21, 2008 8:00 AM UTC

CollaGenex began a U.S. Phase II trial to compare once-daily becocalcidiol to placebo and dovonex in 300 patients for 12 weeks. QuatRx granted CollaGenex exclusive rights outside of Japan for becocal...